If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent corrections.
General rightsCopyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights. •Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research. •You may not further distribute the material or use it for any profit-making activity or commercial gain •You may freely distribute the URL identifying the publication in the Research Portal Download date: 11. Jul. 2022 • [ 18 F]FDG PET/CT may help detect and facilitate monitoring of immunotherapy toxicity and help distinguish toxicity from disease progression or alternative inflammatory or infective pathology. (page 12) • Novel radiopharmaceuticals provide an opportunity to better characterize individual tumors and help define the immune tumor microenvironment. In vivo whole-body and longitudinal molecular imaging may allow dynamic real-time assessment and direct therapeutic approaches. (page 15